Jan 20 (Reuters) - Japan's Shionogi & Co 4507.T said on Tuesday it would pay $2.13 billion for new shares in joint venture ViiV Healthcare, increasing its stake in the HIV drugmaker to 21.7% as U.S. drugmaker Pfizer PFE.N exits its 11.7% stake.
British drugmaker GSK GSK.L will retain its 78.3% majority stake in ViiV Healthcare.
(Reporting by Yadarisa Shabong in Bengaluru; Editing by Rashmi Aich)
((Yadarisa.Shabong@thomsonreuters.com; +91 9742735150;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.